Zhengye Biotechnology Holding (ZYBT) Shares Outstanding (2022 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Shares Outstanding (Entity) for 4 consecutive years, with $47.4 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 3.78% year-over-year to $47.4 million in Q4 2025; TTM through Dec 2025 was $47.4 million, a 3.78% increase from a year earlier, with the FY2025 full-year figure at $47.4 million, up 3.78% from the prior year.
• Shares Outstanding (Entity) was $47.4 million for Q4 2025 at Zhengye Biotechnology Holding, up from $45.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $47.4 million in Q4 2025 and troughed at $40.0 million in Q4 2022.
• A 4-year average of $44.7 million and a median of $45.7 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) climbed 14.17% in 2023 and changed 0.0% in 2024, its largest moves.
• Over 4 years, Shares Outstanding (Entity) stood at $40.0 million in 2022, then rose by 14.17% to $45.7 million in 2023, then changed by 0.0% to $45.7 million in 2024, then climbed by 3.78% to $47.4 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $47.4 million (Q4 2025), $45.7 million (Q4 2024), and $45.7 million (Q4 2023), per Business Quant data.